Proton therapy systems developer Mevion Medical has delivered the superconducting synchrocyclotron accelerator for its Mevion S250, which is presently under installation at the Peggy and Charles Stephenson Cancer Center at the University of ...
Mevion Medical Systems, a radiation therapy company, has received FDA 510(k) clearance for its MEVION S250 Proton Therapy System. The MEVION S250, powered by a patented TriNiobium Core, provides the delivers precise and intense proton ...
Tags: Mevion Medical, FDA 510(k)clearance, MEVION S250, Proton Therapy System